Rogers, Arizona Clinical Trials

A listing of Rogers, Arizona clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

Ironwood Cancer & Research Centers - Chandler
 (3.0 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +227 other locations
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

sickle cell disease
malaise
chronic disease
headache
fever
Arizona Clin Trials-Mesa
 (1.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
mini-mental state examination
alzheimer's disease
flortaucipir
positron emission tomography
Gilbert Neurology
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +85 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

preventive medication
headache
lasmiditan
ly573144
treatment regimen
Clinical Research Consortium
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
Multi-center Open-label Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

Primary Objectives: To evaluate the safety and tolerability of isatuximab administered subcutaneously (SC) versus intravenously (IV) To evaluate the pharmacokinetics (PK) of SC and IV isatuximab Secondary Objectives: To estimate absolute bioavailability of SC and IV isatuximab To measure receptor occupancy (RO) after isatuximab SC versus IV administration To assess …

hepatitis
isatuximab
measurable disease
therapy
dexamethasone
Investigational Site Number 8400005
 (6.5 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +12 other locations
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

mini-mental state examination
galantamine
amyloid
donepezil
amyloidosis
Cognitive Clinical Trials
 (7.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +8 other locations
Registry of Asthma Patients Initiating DUPIXENT

The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT in a real-world setting. The secondary objectives of the study are: To characterize real-world use patterns of DUPIXENT for asthma To assess the long-term effectiveness of DUPIXENT in asthma patients in a …

Regeneron Study Site
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location